【新天药业:感冒止咳胶囊上市许可持有人变更获批,150万元待支付】新天药业公告,公司此前拟将4个药品上市许可及相关生产技术转让给贵州信安堂集团制药有限公司。2026年9月14日,购买方收到《药品补充申请批准通知书》,感冒止咳胶囊药品上市许可持有人变更获批,药品批准文号不变;此前已支付第一期转让款60万元,按合同将支付第二期合同转让款人民币150万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.